Skip to evidence report

EPI.thymic_cortical.Notch_interface: Studies

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 298 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 1–1,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for EPI.thymic_cortical.Notch_interface
#Trait / studyIndividual trait IDMean IC score
1Eustachian tube disorders (PheCode 381.2)GCST90475904179.73
2COX5B/METAP1D ratioGCST90314201148.78
3DECR1/STX8 ratioGCST90314452145.36
4CCL22 levelsGCST90240490138.39
5CALCOCO1/TBC1D5 ratioGCST90313610126.63
6Hypertensive Heart DiseaseFING00000639120.28
7Benign lipomatous neoplasm of skin and subcutaneous tissue of trunkFING00000150110.33
8AcneFING00000010105.07
9Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)FING00000316103.83
10CERT/MAX ratioGCST9031402896.95
11Seborrhoeic keratosisFING0000128396.18
12MAVS/MYO9B ratioGCST9031539094.69
13Triacylglycerol (48:2) [NL-16:0] levelsGCST9002514392.92
14Plasma X-24947 levels in chronic kidney diseaseGCST9026681691.33
15CD48 levelsGCST9042567687.46
16MITD1/WWP2 ratioGCST9031545884.71
17OsteoarthritisGCST9047638384.44
18PLXNA4/USP8 ratioGCST9031569083.07
19DTI autoptx MD unc l tractGCST9038524579.57
20CALCOCO1/CRACR2A ratioGCST9031359876.17
21DTI autoptx L2 unc l tractGCST9038519175.33
22Colorectal cancer, excluding all cancers (controls excluding all cancers)FING0000031773.75
23CERT/PRTFDC1 ratioGCST9031402971.81
24Urine glycine conjugate of C10H14O2 (1)* levels in chronic kidney diseaseGCST9026527471.33
25DNMBP/TJAP1 ratioGCST9031452170.69
26RFC4 levelsGCST9047046070.27
27Other specified and unspecified disorders of lensFING0000110168.43
28DFFA/SIRT2 ratioGCST9031446267.81
29HNRNPK/USP8 ratioGCST9031507067.04
30ICD10 N84: Polyp of female genital tractGCST9045421666.79
31Reaction timeGCST00349966.00
32MAX/TDRKH ratioGCST9031540664.42
33CLEC1A levelsGCST9042423162.19
34Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T73ECGA00007361.38
35FOXO3/SH2B3 ratioGCST9031488161.06
36CDK8_CCNC levelsGCST9024082560.86
37Hard cheese likingGCST9009477859.74
38ADH4/KRT18 ratioGCST9031319259.58
39TNFRSF11B levelsGCST9024315859.42
40Benign lipomatous neoplasmFING0000014658.98
41Right-hemisphere limbic network to hippocampus white-matter structural connectivityGCST9030283157.67
42IL27 levelsGCST9001201757.00
43MAX/STK24 ratioGCST9031540456.73
44QC dMRI-to-T1 linear alignment discrepancyGCST9000635155.76
45Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T475ECGU00047555.39
46COMP/THBS4 ratioGCST9031419354.18
47Psoriasis (vulgaris), strict definitionFING0000122354.01
48Benign neoplasm of other and unspecified endocrine glandsFING0000015953.92
49Urine X-24798 levels in chronic kidney diseaseGCST9026680253.60
50Glycated hemoglobin levelsGCST9056642452.31
51X-18601 levelsGCST9024350152.18
52CASP10/PRTFDC1 ratioGCST9031362752.09
53Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T474ECGU00047451.40
54Turnip likingGCST9009486151.14
55Lysoalkylphosphatidylcholine (O-24:0) levelsGCST9002419750.92
56COX5B/FXN ratioGCST9031419950.07
57CD74/DLL1 ratioGCST9031389149.88
58APOL1 levelsGCST9046834149.86
59Noninfectious gastroenteritis | digestiveUKBB0000052649.81
60Skin brightnessGCST9050277749.81
61T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 82)GCST9032064549.33
62CFI levelsGCST9046873048.96
63How many years have you or did you smoke cigarettes? (inv-normal transformed)GCST9047639048.66
64CDSN/KLK8 ratioGCST9031399648.57
65STX8/USP8 ratioGCST9031589648.18
66aparc-a2009s rh volume G+S-subcentralGCST9000300247.87
67NFX1 levelsGCST9047004147.74
68Sphingomyelin (d18:2/23:0, d18:1/23:1, d17:1/24:1) levelsGCST9020003347.11
69METAP1D/PLXNA4 ratioGCST9031542747.10
70VEGFA levelsGCST9001199547.05
71ICD10 N92: Excessive, frequent and irregular menstruationGCST9045422146.81
72IDP dMRI TBSS MD Cingulum cingulate gyrus RGCST9000406146.59
73Marzipan likingGCST9009479745.67
74Adenocarcinoma and papilloma adenocarcinoma of rectumFING0000003945.56
75Basophil percentage of white cells varianceGCST9056568844.84
76Viral warts & HPV (PheCode 78)GCST9047555544.82
77Gamma-CEHC levelsGCST9019986444.28
78CD40LG/EGF ratioGCST9031381943.76
79Retinal detachments and breaksFING0000126043.62
80Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T473ECGU00047343.61
81SF3B4/SIRT2 ratioGCST9031583843.32
82BANK1/FOXO1 ratioGCST9031345642.93
83LEP levelsGCST00336842.52
84INPP1/NT5C3A ratioGCST9031517742.50
85Cardiac dysrhythmias | circulatory systemUKBB0000011942.44
86Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T476ECGU00047642.35
87Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T115ECGU00011542.27
88SCAMP3/STX4 ratioGCST9031580542.25
89DTI TBSS L2 Posterior thalamic radiation RGCST9038450441.69
90IZUMO4 levelsGCST9042379241.67
91Infections of the skin and subcutaneous tissueFING0000067041.40
92NELL1 levelsGCST9024248141.30
93Unruptured cerebral aneurysmGCST9001859641.17
94Bullous keratopathyFING0000023140.96
95Acute peritonitisFING0000002840.75
96Physical activity (Total log acceleration 12am-2am)GCST9006140940.69
97Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T72ECGA00007240.47
98Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T223ECGU00022340.44
99FGR levelsGCST9046923640.36
100ANXA3 levelsGCST9046831840.28
101PLAU/PLAUR ratioGCST9031567440.00
102BACH1/CNST ratioGCST9031343639.92
103SFRP2 levelsGCST9024272739.89
104CD74/IL18BP ratioGCST9031389239.85
105Mean corpuscular hemoglobin concentrationGCST00460539.84
106CA4/TGFBR2 ratioGCST9031358839.79
107aparc-pial lh area postcentralGCST9000316239.76
108Volume of left medial nucleusGCST9047497639.74
109NUDT5/RWDD1 ratioGCST9031558039.69
110Other menopausal disordersFING0000107139.65
111EREG/GYS1 ratioGCST9031470139.62
112AKT1S1/MAX ratioGCST9031323039.56
113DARS1/USP8 ratioGCST9031440739.43
114Do you currently smoke cigarettes?GCST9047638839.27
115Phenylalanine levels (UKB data field 23468)GCST9026956539.15
1163-hydroxybutyrate levels (UKB data field 23474)GCST9026957139.14
117Biological Father: Coronary Artery / Coronary Heart DiseaseGCST9047524139.07
118APBB1IP/POLR2F ratioGCST9031330039.05
119CXCL11/ITGB1BP2 ratioGCST9031433538.96
120Glucose levelsGCST9013272438.63
121LBR/MAD1L1 ratioGCST9031529538.54
122INPP1/TBCC ratioGCST9031518038.53
123Clonal haematopoiesis of indeterminate potential (ASXL1 mutation)GCST9016525938.12
124KIAA2013 levelsGCST9046967938.06
125FUT8/SPARC ratioGCST9031489337.96
126CALCOCO1/DCTN1 ratioGCST9031360037.93
127RBM17 levelsGCST9047043437.75
128ATXN10/PRTFDC1 ratioGCST9031339837.53
129Type of accommodation lived in - A house or bungalow | HouseholdUKBB0000086937.45
130acne vulgarisGCST9024581837.45
131Colon cancerGCST9001181137.18
132SCARF1/SUSD1 ratioGCST9031581137.07
133Sporadic miscarriageGCST01188836.88
1341-(1-enyl-palmitoyl)-2-oleoyl-gpc (p-16:0/18:1) levelsGCST9020005736.87
135SARG levelsGCST9047052636.84
136End stage renal disease (PheCode 585.32)GCST9047612636.71
137Retinal vascular disordersFING0000126236.67
138CCL19 levelsGCST9027476536.58
139DTI autoptx L3 unc l tractGCST9038521836.41
140Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)FING0000004136.31
141GP1BA/SIAE ratioGCST9031495936.09
142Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T116ECGU00011635.76
143BA-exvivo rh volume BA1GCST9000284935.43
144TRAF2/WWP2 ratioGCST9031594335.43
145PLXNB3/SNAP23 ratioGCST9031569335.26
146FAS levelsGCST9042770235.22
147Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T477ECGU00047735.07
148SnoringGCST00976035.03
149Feeling lonelyGCST00694234.94
150PDGFB/USP8 ratioGCST9031563334.85
151CDKN2D/ITGB1BP2 ratioGCST9031398734.62
152Left-hemisphere limbic network to right-hemisphere limbic network white-matter structural connectivityGCST9030273334.47
153CAG-177 sp003538135 abundance in stoolGCST9003226034.38
154Main speciality of consultant (recoded) - Gastroenterology | Summary AdministrationUKBB0000041534.28
155PsoriasisFING0000122234.10
156ALOX15B levelsGCST9061754734.10
157ATXN10/CASP10 ratioGCST9031339634.01
158CD84/VASH1 ratioGCST9031392033.88
159AXL/GAS6 ratioGCST9031341933.83
160MAP4K5/STAMBP ratioGCST9031538233.66
161Takes medication for enlarged prostate (Benign prostatic hyperplasia)?GCST9047526233.61
162EREG/TIMP3 ratioGCST9031470833.59
163GP6/SCARF1 ratioGCST9031496933.41
164aparc-DKTatlas lh volume caudalmiddlefrontalGCST9000286433.40
165FKBP4/SIRT2 ratioGCST9031484133.34
166STK11/USP8 ratioGCST9031589233.33
167FSTL3/LTBR ratioGCST9031488333.32
168aparc-DKTatlas lh area entorhinalGCST9000323833.24
169aparc-pial lh area caudalmiddlefrontalGCST9000314433.16
170HBEGF levelsGCST9001206733.15
171C8B levelsGCST9046850332.84
172Endometriosis of rectovaginal septum and vaginaFING0000050332.79
173Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T121ECGU00012132.77
174Psoriasis vulgarisFING0000122432.72
175NUDT5/SERPINB1 ratioGCST9031558132.65
176EFNB2 levelsGCST9046908232.57
177MMP9/PLAUR ratioGCST9031547032.55
178aparc-DKTatlas lh volume caudalanteriorcingulateGCST9000286332.39
179Non-seminoma of testis, excluding all cancers (controls excluding all cancers)FING0000087432.31
180Phenylalanine levelsGCST9009293632.28
181MPHOSPH8/USP8 ratioGCST9031547932.27
182AARSD1/UBAC1 ratioGCST9031313532.07
183Heart failure and coronary heart diseaseFING0000060432.02
184CHMP6 levelsGCST9046874732.01
185Conduction disordersFING0000032431.98
186HealthspanGCST00740631.96
187HBEGF/YES1 ratioGCST9031503931.89
188ANXA3/ANXA4 ratioGCST9031327831.81
189CA4/TNFSF12 ratioGCST9031358931.77
190Other disorders of skin and subcutaneous tissueFING0000103531.64
191GFRAL levelsGCST9046933131.31
192CSTB levelsGCST9017927231.19
193TMSB10/TXNRD1 ratioGCST9031592531.18
194DOK2/PPP1R12A ratioGCST9031453630.99
195Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders (more control exclusions)FING0000010130.97
196CD40LG/GP6 ratioGCST9031382230.96
197TBCC/WWP2 ratioGCST9031591130.94
198GRAP2/LACTB2 ratioGCST9031498030.76
199Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T77ECGA00007730.65
200KLK8/LY6D ratioGCST9031525730.64
201Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)FING0000077130.63
202IGF2R/RNASET2 ratioGCST9031513230.62
203CXCL5 levelsGCST9000046130.62
204DTI TBSS FA Posterior thalamic radiation RGCST9038440830.52
205DECR1/FXN ratioGCST9031444630.41
206T1 FreeSurfer BA lh BA3a exvivo thicknessGCST9038552130.36
207Plasma 3-hydroxybutyroylglycine** levels in chronic kidney diseaseGCST9026448830.31
208GAL levelsGCST9046930030.27
209Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T71ECGA00007130.19
210CD40/IGSF8 ratioGCST9031381530.13
211IDP dMRI TBSS MO Cerebral peduncle LGCST9000396729.98
212Normotensive glaucomaFING0000089229.81
213ATP5IF1/HSPA1A ratioGCST9031338829.70
214EGF/MPIG6B ratioGCST9031461129.69
215CD40/TNFRSF14 ratioGCST9031383029.61
216ARL13B levelsGCST9046836329.51
217CLU levelsGCST9046879329.32
218CD164/NUDT5 ratioGCST9031374229.12
219Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T471ECGU00047129.06
220Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T478ECGU00047829.01
221APP/EGF ratioGCST9031332229.00
222Glycerophosphorylcholine (GPC) levelsGCST9019962929.00
223Acquired foot deformities (PheCode 735)GCST9047624728.99
224DTI autoptx FA slf r tractGCST9038513428.95
225Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T74ECGA00007428.85
226GYS1/TIA1 ratioGCST9031500428.81
227HGF/MMP9 ratioGCST9031505628.75
228aparc-a2009s lh volume G-postcentralGCST9000295228.74
229FAP/THBS4 ratioGCST9031478528.60
230Principal component-derived dietary pattern 16GCST9013302128.47
231MESD/WWP2 ratioGCST9031542628.44
232DIABLO/VSIR ratioGCST9031447028.43
233Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T117ECGU00011728.26
234Ankylosing spondylitis, strict definitionFING0000009028.21
235Colon cancer (PheCode 153.2)GCST9047556728.18
236Deep endometriosisFING0000038228.02
237SERPINE1/USP8 ratioGCST9031583527.99
238COMP/TGFBI ratioGCST9031419227.92
239DCTN1/SCAMP3 ratioGCST9031443327.88
240Beta-hydroxyisovaleroylcarnitine levelsGCST9019980227.79
241CALCOCO1/VPS53 ratioGCST9031361227.71
242IDP T1 FIRST right putamen volumeGCST9000244127.69
243FHIT/MAX ratioGCST9031481827.62
244SERPINE1/VASH1 ratioGCST9031583627.59
245UrticariaGCST9001871627.46
246total creatine kinase (minimum, inv-norm transformed)GCST9047641627.32
247PPP1R12A/TXNDC5 ratioGCST9031571427.31
248Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T470ECGU00047027.28
249NTF4 levelsGCST9047009527.27
250TEX101 levelsGCST9047083227.24
251DLL1/IL18BP ratioGCST9031449527.20
252DCTN6 levelsGCST9046896027.19
253CAG-776 abundance in stoolGCST9003229727.18
254CLEC1B/VSIR ratioGCST9031410627.16
255CMIP levelsGCST9046879527.09
256Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T482ECGU00048227.09
257LYN/YES1 ratioGCST9031535127.07
258CST3/IGFBP6 ratioGCST9031429327.04
259Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T222ECGU00022227.01
2601-(1-enyl-palmitoyl)-2-linoleoyl-GPC (p-16:0/18:2) levelsGCST9020006026.90
261DRG2/SEMA4D ratioGCST9031455426.74
262LCN2/RETN ratioGCST9031530826.69
263PDGFA/USP8 ratioGCST9031562126.66
264Left ventricular end diastole anterospetal wall thicknessGCST9027851926.64
265COMP/ICAM1 ratioGCST9031418926.61
266Other and unspecified disorders of vitreous bodyFING0000093426.60
267AXL levelsGCST9046840626.49
268CPPED1 levelsGCST9046884526.31
269X-23641 levelsGCST9020060326.30
270Severe, life-threatening illness (confirmatory factor analysis Factor 20)GCST9030935426.30
271PPIF levelsGCST9047029326.27
272PLAUR levelsGCST9047025126.12
273FKBP5/MITD1 ratioGCST9031484425.88
274Congenital malformations of the circulatory systemFING0000034025.73
275USP8 levelsGCST9047102225.64
276Tyrosine levels (UKB data field 23469)GCST9026956625.54
277aparc-a2009s lh area G-postcentralGCST9000332425.52
278Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T467ECGU00046725.49
279CCN2/SERPINB1 ratioGCST9031371525.49
280DCTN1/FXN ratioGCST9031443025.46
281DTI autoptx L2 ptr r tractGCST9038518625.46
282IDI2 levelsGCST9046950525.44
283Emotional abuseGCST9055184525.37
284Lupus erythematosusFING0000073925.34
285Dermatitis due to ingested foodFING0000040325.32
286Potatoes likingGCST9009481625.29
287FUT8/RSPO1 ratioGCST9031489125.27
288aparc-Desikan lh volume caudalmiddlefrontalGCST9000277125.20
289Myo-inositol levelsGCST9024352725.07
290GLOD4/HSPA1A ratioGCST9031493724.81
291Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T114ECGU00011424.77
292aparc-DKTatlas lh volume rostralmiddlefrontalGCST9000288724.75
293Pelvic widthGCST9044891124.73
2941-palmitoyl-2-oleoyl-GPE (16:0/18:1) metabolite levelGCST9061640324.68
295Peritonsillar abscessFING0000116024.65
296DTI TBSS L2 Anterior corona radiata LGCST9038449924.53
2971-(1-enyl-palmitoyl)-GPC (p-16:0) levelsGCST9019989924.49
298SKAP2/VSIR ratioGCST9031584924.46
299IDP dMRI TBSS MO Posterior limb of internal capsule LGCST9000397124.45
300Raw carrot likingGCST9009481824.38
301IDP dMRI TBSS MO Posterior limb of internal capsule RGCST9000397024.27
302CRADD/HSPA1A ratioGCST9031423924.17
303DTI autoptx FA fmi tractGCST9038512324.14
304CD84/GP6 ratioGCST9031391424.14
305STK24/TDRKH ratioGCST9031589324.14
306DOK1 levelsGCST9046902824.09
307GP6/SEMA4D ratioGCST9031497124.08
308BAG6/USP8 ratioGCST9031345124.05
309Types of physical activity in last 4 weeks - Other exercises (eg: swimming, cycling, keep fit, bowling) | Physical activityUKBB0000087324.01
310MTSS2 levelsGCST9046996124.00
311PRKAR1A/SNAP23 ratioGCST9031572823.97
312SH2B3/SUGT1 ratioGCST9031584023.90
313FAM174A levelsGCST9024191423.89
314CRIP2/SNCG ratioGCST9031426223.88
315DTI autoptx L2 ifo l tractGCST9038517823.81
316DUSP29 levelsGCST9046905223.80
317Phosphatidylcholine (34:5) levelsGCST9002428623.75
318Cerebrospinal fluid S-1-pyrroline-5-carboxylate levelsGCST9031823523.73
319Suicide or other Intentional self-harmFING0000134523.71
320Left-hemisphere default mode network to putamen white-matter structural connectivityGCST9030276923.62
321Plasma N,N,N-trimethyl-5-aminovalerate levels in chronic kidney diseaseGCST9026567123.58
322IMPA1/TBCC ratioGCST9031517523.55
323Plasma propionylcarnitine (C3) levels in chronic kidney diseaseGCST9026587623.51
324aparc-pial rh area caudalmiddlefrontalGCST9000317723.51
325Aplastic anemiaGCST9001857423.50
326DTI TBSS MD Sagittal stratum LGCST9038460323.50
327Volume of right central nucleusGCST9047502423.46
328ARNT levelsGCST9046836723.42
329PDZK1 levelsGCST9047020323.34
330ALCAM/SPINT1 ratioGCST9031324223.31
331T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 80)GCST9032064323.28
332QC rfMRI-to-T1 linear alignment discrepancyGCST9000635323.19
333T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 122)GCST9032094123.14
334Phosphatidylglycerol (34:1) levelsGCST9002506123.11
335Red cell distribution widthGCST00462123.10
336Psoriatic arthropathiesFING0000122523.06
337HGF/PLAUR ratioGCST9031505923.03
338Clonal haematopoiesis of indeterminate potential (TET2 mutation)GCST9016528122.99
339MYOC levelsGCST9042282522.96
340CAG-776 sp000438195 abundance in stoolGCST9003229622.93
341Polyunsaturated fatty acids to saturated fatty acids ratioGCST9050259722.83
342Left-hemisphere somatomotor network to left-hemisphere limbic network white-matter structural connectivityGCST9030267222.80
343X-17676 levelsGCST9020054822.68
344ILKAP levelsGCST9046960822.67
345PPME1/PSMD9 ratioGCST9031570522.63
346MICB_MICA/TEK ratioGCST9031544622.61
347AFM levelsGCST9046824922.60
348T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 78)GCST9032089722.58
349CD40 levelsGCST9001206522.58
350ACTA2 levelsGCST9046820822.57
351TNF/TNFRSF1B ratioGCST9031594222.52
352Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T58ECGA00005822.40
353XRCC4 levelsGCST9047108522.38
354Bundle branch block (PheCode 426.3)GCST9047595622.31
355Arthropathies in other diseases classified elsewhereFING0000010822.28
356DAPP1/ITGB1BP2 ratioGCST9031438822.20
357Operation code - squint correction | OperationsUKBB0000056622.13
358Other predominantly sexually transmitted diseases, not elsewhere classifiedFING0000108922.09
359DTI autoptx L2 ilf r tractGCST9038518122.09
360Glaucoma, exfoliationFING0000058022.03
361Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T120ECGU00012022.03
362Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T472ECGU00047221.98
363SnoringGCST00976121.95
364Left-hemisphere default mode network to caudate white-matter structural connectivityGCST9030276821.95
365LCN2/S100A12 ratioGCST9031530921.86
366aparc-a2009s rh area G+S-subcentralGCST9000337421.84
367METAP2/USP8 ratioGCST9031543421.81
368COMP/DPP4 ratioGCST9031418821.75
369FST levelsGCST9001208021.73
370CASP3/CRKL ratioGCST9031363121.72
371ARTN levelsGCST9046837221.70
372HJV levelsGCST9046945521.60
373Autorefraction - 6mm strong meridian angle (right) | EyesightUKBB0000007821.59
374PSPN levelsGCST9047036421.58
375X-12510--2-aminooctanoic acid levelsGCST9024374821.57
376CST6/GAL ratioGCST9031430221.54
377Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T118ECGU00011821.48
378aparc-Desikan lh area postcentralGCST9000309421.42
379Autorefraction - 6mm asymmetry index (left) | EyesightUKBB0000007321.42
380Tyrosine levelsGCST9009299321.41
381SPINT1 levelsGCST9024171721.37
382Blood cell traits latent factor 21 (red cell)GCST9055926321.30
383DTI autoptx L3 ifo l tractGCST9038520521.30
384Retinoschisis and retinal cysts (PheCode 361.2)GCST9047584621.24
385Urinary ethanolamine to urinary creatinine ratioGCST9045171721.16
386CLMP/GFRA1 ratioGCST9031413321.13
387Dihomo-linoleoylcarnitine (C20:2) levelsGCST9020014421.11
388GABARAPL1 levelsGCST9046928721.04
389Operation code - wisdom teeth surgery | OperationsUKBB0000056920.99
390FHIT/PRTFDC1 ratioGCST9031482320.98
391Other demyelinating diseases of the central nervous systemFING0000099520.97
392PRTFDC1 levelsGCST9047034620.90
393FOXO1/USP8 ratioGCST9031487920.89
3945alpha-androstan-3alpha,17beta-diol monosulfate (1) levelsGCST9019985820.86
395DNMBP/PTPN1 ratioGCST9031451720.81
396Neutrophil countGCST9000235120.66
397Left-hemisphere somatomotor network to left-hemisphere control network white-matter structural connectivityGCST9030267320.60
398EPO/TFRC ratioGCST9031468420.58
399CPB2 levelsGCST9046884020.58
400REST UKBBICA NET100 1212GCST9038706620.56
401Milk type used - Full cream | DietUKBB0000046820.55
402Aniseed likingGCST9009468920.53
403Colorectal cancer (PheCode 153)GCST00837220.40
404Types of transport used (excluding work) - Walk | Physical activityUKBB0000087920.26
405Ulcer of lower limb, not elsewhere classifiedFING0000138520.23
406Heart failure, strictFING0000060620.21
407SIRT2/STAT5B ratioGCST9031584620.16
408APP/NID2 ratioGCST9031332720.15
409Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T452ECGU00045220.15
410ITGB1BP2/WASF1 ratioGCST9031522420.13
411Total Phosphatidylethanolamine levelsGCST9002520720.11
412DIABLO/PRKAR1A ratioGCST9031446920.07
413Colorectal cancer (PheCode 153)GCST9047556620.04
414ExotropiaGCST9057273720.02
415ST6GALNAC2 levelsGCST9024025119.94
416Otitis externaFING0000112819.93
417SERPINB1/TMSB10 ratioGCST9031583019.91
418Blood cell traits latent factor 14 (red cell)GCST9055925619.89
419Red cell distribution widthGCST9000236919.81
420Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T64ECGA00006419.78
421PDCD6IP levelsGCST9061896919.76
422STAMBP/WWP2 ratioGCST9031588819.75
423S100A12 levelsGCST9047051319.74
424CD40LG/MPIG6B ratioGCST9031382519.72
425TANK levelsGCST9047080319.67
426CX3CL1 levelsGCST9027477819.66
427RBKS levelsGCST9047043319.63
428Nontoxic uninodular goiter (PheCode 241.1)GCST9047564019.61
429Omega-3 fatty acid levelsGCST9050205519.54
430Acne (PheCode 706.1)GCST9047621119.53
431Red cell distribution widthGCST9000240419.52
432MAP2K6/MGMT ratioGCST9031537319.47
433BMPER levelsGCST9046845519.42
434BLVRB/HAGH ratioGCST9031352419.40
435IL19 levelsGCST9046956819.39
436Saturated fatty acids to total fatty acids percentageGCST9050268519.38
437total creatine kinase (maximum, inv-norm transformed)GCST9047641019.33
438Takes medication for Chronic lung diseases including COPD, Emphysema and Bronchitis?GCST9047527319.29
439Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T85ECGA00008519.22
440Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T481ECGU00048119.20
441SF3B4 levelsGCST9047060919.18
442DBNL/HSPA1A ratioGCST9031441819.16
443Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T78ECGA00007819.16
444GRHPR levelsGCST9046940019.14
445DTI autoptx L2 slf l tractGCST9038518719.08
446Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T81ECGU00008119.05
447NEO1 levelsGCST9047002919.02
448CCL13/CCL2 ratioGCST9031367519.00
449ENAH levelsGCST9046910619.00
450PSME2/RBKS ratioGCST9031573719.00
451IL7 levelsGCST9046960619.00
452BTN2A1/IL18BP ratioGCST9031354518.96
453DKK1/SERPINE1 ratioGCST9031448018.88
454CRKL/PLA2G4A ratioGCST9031427118.86
455aparc-DKTatlas lh volume postcentralGCST9000288218.83
456PKLR/UBAC1 ratioGCST9031566018.77
457T1 FreeSurfer DK lh lateraloccipital areaGCST9038559818.74
458Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T84ECGA00008418.70
459T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 44)GCST9032060718.69
460Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T221ECGU00022118.68
461NRGN levelsGCST9047008318.63
462T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 117)GCST9032068018.62
463COL28A1 levelsGCST9046881518.62
464Corns and callosities (PheCode 700)GCST9047619618.61
465IDP T1 FAST ROIs L subcallosal cortexGCST9000250318.54
466Felt very upset when reminded of stressful experience in past month | Traumatic eventsUKBB0000024318.53
467aparc-a2009s rh volume G-postcentralGCST9000302618.47
468aparc-Desikan rh area caudalmiddlefrontalGCST9000311018.45
469EGF/PPIB ratioGCST9031461218.45
470Red blood cell (erythrocyte) distribution width | Blood countUKBB0000074818.42
471AKT2 levelsGCST9046827718.40
472GTPBP2 levelsGCST9046941718.39
473CFB levelsGCST9046872318.31
474total creatine kinase (mean, inv-norm transformed)GCST9047641318.30
475T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 41)GCST9032060418.30
476T1 FreeSurfer aseg MaskVol-to-eTIVGCST9038419218.20
477End-diastolic bi-ventricular shape (principal component 5)GCST9044848418.19
478Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T479ECGU00047918.19
479PTPN1/SCAMP3 ratioGCST9031574318.16
480Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T491ECGU00049118.15
481PMVK levelsGCST9047027218.15
482Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T63ECGA00006318.08
483Margaroylcarnitine (C17) levelsGCST9019992918.07
484Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T290ECGA00029018.07
485SERPINB1/SERPINB9 ratioGCST9031582718.06
486CCN3/FAP ratioGCST9031372117.99
487RELL1 levelsGCST9024262517.96
488TBL1X levelsGCST9047081517.95
489Obstructive chronic bronchitis (PheCode 496.21)GCST9047603017.95
490ANXA3/ENO2 ratioGCST9031328117.94
491DTI autoptx FA ilf r tractGCST9038512717.93
492FNDC1 levelsGCST9046925617.93
493USP8/WASF1 ratioGCST9031594417.88
494APCS levelsGCST9042846317.81
495DTI autoptx FA slf l tractGCST9038513317.79
496PollinosisGCST9001868317.73
497ALDH1A1/RBKS ratioGCST9031324717.73
498CD2AP/USP8 ratioGCST9031378417.71
499NOS1 levelsGCST9047006217.70
500GPI levelsGCST9046939117.70
501VNN2 levelsGCST9047104417.64
502Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T62ECGA00006217.64
503Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T60ECGA00006017.64
504ANGPT1/DKK1 ratioGCST9031326317.62
505aparc-Desikan lh volume postcentralGCST9000278917.60
5063-methyl-2-oxovalerate levelsGCST9024348517.54
507DTI TBSS L3 Sagittal stratum LGCST9038455517.53
508IRAK1/NFATC1 ratioGCST9031519417.39
509Non-ischemic cardiomyopathyFING0000087317.37
510Tiglylcarnitine (C5:1-DC) levelsGCST9019980017.35
511Omega-6 fatty acids to total fatty acids percentageGCST9050254517.34
512Phosphatidylethanolamine (38:4) levelsGCST9048826117.33
513PLAUR levelsGCST9001205117.31
514Right-hemisphere visual network to right-hemisphere control network white-matter structural connectivityGCST9030277917.28
515AHCY/HSPA1A ratioGCST9031321117.27
516Intrahepatic Cholestasis of Pregnancy (ICP)  (more control exclusions)FING0000069217.25
517DTI autoptx L2 ifo r tractGCST9038517917.22
518aparc-pial lh area rostralmiddlefrontalGCST9000316717.21
519X-24337 levelsGCST9020062917.21
520CFHR1 levelsGCST9061850317.20
521SCARA5/TNC ratioGCST9031581017.15
522aparc-DKTatlas rh area caudalmiddlefrontalGCST9000326717.12
523DTI TBSS MD Uncinate fasciculus RGCST9038461617.11
524AMBP/EFEMP1 ratioGCST9031325317.10
525MMP9 levelsGCST9046992317.09
526MAP4K5 levelsGCST9046985517.07
527FADD/PLIN3 ratioGCST9031477217.06
528CXCL10 levelsGCST9027478017.06
529Disorders of choroid and retinaFING0000043817.05
530Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T289ECGA00028917.03
531SSH3 levelsGCST9047074917.01
532Pain (PheCode 338)GCST9047583616.91
533DTI TBSS FA Superior longitudinal fasciculus LGCST9038442116.90
534CST6 levelsGCST9046889616.90
535Androsterone sulfate levelsGCST9020067416.88
536Heart failure and bmi 25plusFING0000060316.75
537Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T49ECGA00004916.72
538CRTAC1 levelsGCST9046887016.67
539Medication use (antiglaucoma preparations and miotics)GCST9001878216.62
540CSF3 levelsGCST9046888616.60
541End-diastolic bi-ventricular shape (principal component 9)GCST9044848816.60
542CD84/SDC4 ratioGCST9031391616.59
543Neutrophill count (UKB data field 30140)GCST9046809216.56
544EGF levelsGCST9046908616.55
545NFKB1 levelsGCST9047003716.53
546Atherosclerosis of native arteries of the extremities with intermittent claudication (PheCode 440.22)GCST9047599116.51
547FOLH1 levelsGCST9046925816.47
5483-methyl-2-oxobutyrate levelsGCST9019967716.45
549Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T57ECGA00005716.41
550CETN2/PRTFDC1 ratioGCST9031403016.41
551Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T61ECGA00006116.40
552ADH4 levelsGCST9046824416.39
553FUT8/VEGFC ratioGCST9031489616.39
554Proline levelsGCST9024345716.39
555FKBP4 levelsGCST9046924316.39
556Androstenediol (3alpha, 17alpha) monosulfate (3) levelsGCST9019985616.38
557GBP6 levelsGCST9024136816.30
558Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T86ECGA00008616.29
559CD274/EFNA4 ratioGCST9031376816.29
560METAP2 levelsGCST9046989416.25
561IDP dMRI TBSS MO Middle cerebellar peduncleGCST9000395216.24
562Major depressive disorder (probable)GCST00590416.23
563aparc-Desikan rh volume postcentralGCST9000282216.22
564ThalamNuclei rh volume PuIGCST9000273816.20
565F-healthy breakfast food liking (derived food-liking factor)GCST9009478016.13
566Blood cell traits latent factor 1 (white cell)GCST9055924316.12
567Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T78ECGU00007816.09
568BLVRB/CA3 ratioGCST9031352316.01
569ODAM levelsGCST9047011515.99
570T1 FreeSurfer a2009s lh G precentral volumeGCST9038484415.99
571CCL5/TACC3 ratioGCST9031370715.98
572GRAP2/TYMP ratioGCST9031499015.98
573Red cell distribution widthGCST9002598815.98
574DLL4 levelsGCST9046900515.96
575MFGE8 levelsGCST9046990015.89
576Lung cancerGCST9001181215.88
577Other infective otitis externaFING0000106015.88
578ASRGL1 levelsGCST9046837915.86
579GRSF1 levelsGCST9046940715.83
580aparc-DKTatlas rh volume postcentralGCST9000291315.82
581Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T46ECGA00004615.78
582Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T122ECGU00012215.76
583PPP1R2/USP8 ratioGCST9031572315.71
584SUGT1/TBL1X ratioGCST9031589715.67
585Chronic iridocyclitisFING0000028715.64
586Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T453ECGU00045315.52
587NADK/PXN ratioGCST9031551215.51
588SDK2 levelsGCST9047056215.50
589aseg lh volume Inf-Lat-VentGCST9000261715.44
590F11 levelsGCST9046916515.42
591CA4 levelsGCST9046851315.40
592CST3/TIMP1 ratioGCST9031430015.40
593NUMB levelsGCST9047010815.38
594Bitter ale likingGCST9009470515.36
595IDP dMRI TBSS MO Anterior corona radiata RGCST9000397415.36
596IDP dMRI ProbtrackX MD cgc rGCST9000422415.33
597SDC4 levelsGCST9047055915.32
598Mean corpuscular haemoglobin concentration (UKB data field 30060)GCST9046808515.30
599CCS levelsGCST9046859415.27
600Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T77ECGU00007715.25
601EDAR/ITGB1BP2 ratioGCST9031458015.21
602ALB levelsGCST9001872515.20
603T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 123)GCST9032068615.13
604IDP T1 FAST ROIs L precentral gyrusGCST9000246315.07
605SEZ6 levelsGCST9047060814.98
606Honey likingGCST9009478214.95
607Monoclonal gammopathy of undetermined significanceGCST9062474514.93
608Anal and rectal conditions | digestiveUKBB0000002914.93
609DLK1/FAP ratioGCST9031449114.92
610FXN levelsGCST9046928214.90
611T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 84)GCST9032090314.88
612MITD1 levelsGCST9046991014.87
613Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T488ECGU00048814.87
614Neutrophill count | Blood countUKBB0000049714.86
615CCBL2 levelsGCST9024172214.85
616COMP/ITGAV ratioGCST9031419014.85
617Blood cell traits latent factor 13 (red cell)GCST9055925514.80
618DNM3 levelsGCST9046902214.80
619VPS4B levelsGCST9047104714.79
620DOK2/LACTB2 ratioGCST9031453214.79
621Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T70ECGA00007014.77
622T1 FreeSurfer DKT lh lateraloccipital areaGCST9038420214.77
623Rubneribacter sp002159915 abundance in stoolGCST9003254114.76
624Eicosenoylcarnitine (C20:1) levelsGCST9020014814.69
625Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T82ECGU00008214.69
626T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 101)GCST9032092014.67
627Neutrophil countGCST9000239814.65
628Primary Raynaud’s phenomenonGCST9027171414.65
629MS-disease / Multiple SclerosisFING0000083914.64
630MMP9/OLR1 ratioGCST9031546714.57
631Synovitis and tenosynovitis (PheCode 727.1)GCST9047624214.52
632CLMP/TNFRSF19 ratioGCST9031413614.51
633IL22RA2 levelsGCST9009069914.51
634DTI autoptx L2 fmi tractGCST9038517714.50
635CXCL6/DFFA ratioGCST9031435714.47
636Lysoalkylphosphatidylcholine (O-24:1) levelsGCST9002419814.46
637aparc-DKTatlas rh area precentralGCST9000328714.45
638EGF/GP6 ratioGCST9031460814.45
639Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T59ECGA00005914.45
640DNA methylation Hannum age accelerationGCST9001428914.45
641Mandibular retrognathiaFING0000078414.44
642Dry age-related macular degeneration (includes geographic atrophy)FING0000048014.43
643CCN2/MGLL ratioGCST9031371414.41
644IGSF8/VSIR ratioGCST9031514114.41
645T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 79)GCST9032089814.36
646Destinations on discharge from hospital (recoded) - Usual Place of residence | Summary AdministrationUKBB0000016714.35
647Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T76ECGA00007614.35
648Degree of unsaturationGCST9050222414.33
649HGF/TNFSF14 ratioGCST9031506014.32
650Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T119ECGU00011914.27
651APP/PPP1R12A ratioGCST9031333014.27
652CST6/NECTIN4 ratioGCST9031430314.25
653GAL/PM20D1 ratioGCST9031491714.20
654Retinal detachments and breaks | Disorders of choroid and retinaUKBB0000075514.18
655DAPP1/SDC4 ratioGCST9031439914.16
656Sleep apneaGCST9047582414.13
657Anorexia (incl.atypical)FING0000009314.10
658FABP1/RBP2 ratioGCST9031475314.09
659Plasma X-25279 levels in chronic kidney diseaseGCST9026683514.09
660DCTN1/ERBIN ratioGCST9031442914.09
661Milk type used: Full cream (UKB data field 1418_1)GCST9013293814.05
662CGA levelsGCST9046873214.04
663Linoleoyl-arachidonoyl-glycerol (18:2/20:4) [1] levelsGCST9020010313.99
664T1 CAT volume Vermis VIIIaGCST9038412813.97
665SPRR3 levelsGCST9047073713.96
666CD8 on Effector Memory CD8+ T cellGCST9000205613.95
667GADD45GIP1 levelsGCST9046929313.93
668Deoxycholic acid glucuronide metabolite levelGCST9061622913.93
669Acquired absence of organs, not elsewhere classified | Persons with potential health hazards related to family and personal history and certain conditions influencing health statusUKBB0000000513.92
670Macular puckerFING0000074513.90
671Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T48ECGA00004813.86
672BMP4 levelsGCST9046845313.80
673Sleep disorders | neurologicalUKBB0000077613.80
674Epiandrosterone sulfate levelsGCST9019975213.78
675FOXO1/NFATC1 ratioGCST9031487313.77
676Fibroblastic disorders | Other soft tissue disordersUKBB0000024613.77
677Female genital prolapseFING0000053513.73
678aparc-Desikan rh thickness postcentralGCST9000350013.72
679Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T451ECGU00045113.72
680APP/NID1 ratioGCST9031332613.71
681CD83/LAMP3 ratioGCST9031390613.71
682Carnitine levelsGCST9023999113.69
683Recent trouble relaxing | AnxietyUKBB0000074513.68
684Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T226ECGU00022613.66
685IDP dMRI TBSS ISOVF Superior corona radiata RGCST9000450113.63
686Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T291ECGA00029113.63
687Operative procedures - Closed reduction of fracture of bone and fixation using nail or screw | Summary OperationsUKBB0000057513.57
688Red cell distribution widthGCST00680413.56
689PLXNA4/SPRY2 ratioGCST9031568713.56
690ANGPT1/SERPINE1 ratioGCST9031326913.56
691Other diseases of blood and blood-forming organs, wideFING0000099913.55
692Operation code - spinal laminectomy | OperationsUKBB0000056413.53
693MAX levelsGCST9046986713.53
694STAMBP levelsGCST9047075613.52
695DTI TBSS L2 Anterior corona radiata RGCST9038449813.50
696FKBP4/FKBP5 ratioGCST9031483813.50
697IRAK1 levelsGCST9046962713.49
698MANF/TXNDC5 ratioGCST9031537013.47
699Heel broadband ultrasound attenuation (left) | Bone-densitometry of heelUKBB0000031913.46
700Biliverdin levels in chronic kidney diseaseGCST9025749513.41
701PDGFB/PTPN6 ratioGCST9031562513.40
702ARHGEF10 levelsGCST9046835713.38
703Right-hemisphere limbic network to caudate white-matter structural connectivityGCST9030282813.38
704CASP3/SERPINE1 ratioGCST9031364313.36
705Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T85ECGU00008513.35
706Lysoalkylphosphatidylcholine (O-22:0) levelsGCST9002419513.35
707QC rfMRI cleaned inverse tSNRGCST9000635813.32
708T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 97)GCST9032066013.30
709Ever thought that life not worth living | Self-harm behavioursUKBB0000022513.27
710Gamma-glutamylglycine levelsGCST9019974113.27
711aparc-pial rh area precentralGCST9000319713.23
712CA4/PECAM1 ratioGCST9031358613.23
713SERPINB6/TXNDC5 ratioGCST9031583213.23
714SNX9/STIP1 ratioGCST9031586413.20
715EGFR/FAP ratioGCST9031461313.18
716Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T480ECGU00048013.17
717DTI TBSS FA Anterior corona radiata LGCST9038440313.17
718GLOD4/MIF ratioGCST9031493913.17
719neutrophil (absolute count, maximum, inv-norm transformed)GCST9047552613.16
720Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T466ECGU00046613.16
721ATP5IF1/FXN ratioGCST9031338613.15
722CD40LG/TRAF2 ratioGCST9031382813.14
723AAGAB levelsGCST9061747313.12
724Recent feelings of inadequacy | DepressionUKBB0000073913.06
725MIA levelsGCST9046990313.04
726Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T186ECGU00018613.03
727Disorders of iris and ciliary body (PheCode 379.5)GCST9047589913.02
728IL15RA levelsGCST9046955512.99
729Physical decline (log-difference score)GCST9056584712.99
730Snoring | SleepUKBB0000078412.96
731Thyroid cancer (PheCode 193)GCST9047560012.95
732Neutrophil countGCST9002597712.93
733Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T468ECGU00046812.92
734Daytime dozing / sleeping (narcolepsy) | SleepUKBB0000016412.90
735IDP dMRI TBSS MD Uncinate fasciculus RGCST9000407112.89
736Nontoxic nodular goiter | endocrine/metabolicUKBB0000052912.89
737F-dairy liking (derived food-liking factor)GCST9009475112.87
738CACNB3 levelsGCST9046852312.85
739Phosphatidylethanolamine_40:6_[M-H]1- levelsGCST9006036512.84
740Pain in limb (PheCode 773)GCST9047627012.83
741neutrophil (absolute count, mean, inv-norm transformed)GCST9047552912.80
742CCL14/CST3 ratioGCST9031367912.80
743ATOX1 levelsGCST9046838512.79
744Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T56ECGA00005612.79
745AmygNuclei lh volume Medial-nucleusGCST9000265312.78
746CD48/SLAMF7 ratioGCST9031384212.77
747CLEC1B/EGF ratioGCST9031408912.75
748Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T65ECGA00006512.74
749Hereditary ataxiaFING0000061012.70
750GP6/SELP ratioGCST9031497012.70
751Blood cell traits latent factor 12 (red cell)GCST9055925412.68
752Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T454ECGU00045412.68
753Ectopic pregnancyFING0000048712.68
754CD40LG/SERPINE1 ratioGCST9031382612.67
755aseg rh volume PutamenGCST9000263912.65
756Kidney volumeGCST9001667012.63
757CASP10 levelsGCST9046854212.63
758Disorders of iron metabolism (PheCode 275.1)GCST9047574312.61
759Other contact dermatitisFING0000099012.61
760SLAMF7/TXNDC15 ratioGCST9031585012.61
761TNFRSF10A levelsGCST9047089912.60
762BAX/MAX ratioGCST9031346612.58
763NAGPA levelsGCST9024200412.58
764red cell diameter width (RDW, maximum, inv-norm transformed)GCST9047635712.57
765CACYBP levelsGCST9046852412.51
766BA-exvivo rh volume BA3bGCST9000285212.51
767HLA-DMA levelsGCST9024144812.50
768ANXA3/HCLS1 ratioGCST9031328212.50
769Moderate-to-vigorous intensity physical activity during leisure timeGCST9010434112.49
770red cell diameter width (RDW, minimum, inv-norm transformed)GCST9047636512.49
771Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T55ECGA00005512.47
772Fracture of lumbar spine and pelvisFING0000055612.47
773Total bile acid levels in pregnancyGCST9045419812.46
774SYTL4 levelsGCST9047079512.46
775Histidine levelsGCST9024340412.46
776Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T490ECGU00049012.44
777Left ventricular outflow tract obstruction (LVOTO), broad definitionFING0000071712.44
778CPM/LAMP2 ratioGCST9031421512.43
779Witnessed sudden violent death | Traumatic eventsUKBB0000091712.42
780BACH1/DIABLO ratioGCST9031343712.42
781IDP dMRI TBSS FA Superior fronto-occipital fasciculus RGCST9000391912.40
782APLP1 levelsGCST9046833012.37
783BIRC2/CD40LG ratioGCST9031351712.37
784BRAP levelsGCST9046846412.32
785Divergent concomitant strabismusFING0000047012.26
786Erythematous conditions (PheCode 695)GCST9047617712.24
787Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T489ECGU00048912.22
788Heel Broadband ultrasound attenuation, direct entry | Bone-densitometry of heelUKBB0000032112.21
789MyopiaFING0000085312.20
790Depression or dysthymiaFING0000040012.19
791CKMT1A or CKMT1B levelsGCST9046876012.19
792DTI TBSS L3 Posterior thalamic radiation RGCST9038455212.19
793Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T487ECGU00048712.15
794Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T225ECGU00022512.14
795COL1A1 levelsGCST9046881312.14
796Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T278ECGU00027812.13
797BA-exvivo rh thickness BA4aGCST9000353112.12
798rfMRI amplitudes (ICA100 node 38)GCST9000462612.11
799Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T166ECGA00016612.09
800ITGB1/VASN ratioGCST9031523212.08
801aparc-DKTatlas lh area postcentralGCST9000325412.07
802Right-hemisphere somatomotor network to putamen white-matter structural connectivityGCST9030279612.05
803Phosphatidate_34:2_[M-H]1- levelsGCST9006022312.05
804CKAP4/IL4R ratioGCST9031407212.04
805STAB2 levelsGCST9047075512.04
806HBEGF/LAT2 ratioGCST9031503212.01
807CD59/SCARB2 ratioGCST9031385912.00
808UBXN1 levelsGCST9047100411.99
809Other strabismusFING0000111411.98
810Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T187ECGU00018711.95
811CD59/CST6 ratioGCST9031385711.94
812ATOX1/SPARC ratioGCST9031337511.94
813Recent feelings of foreboding | AnxietyUKBB0000073811.93
814LPP levelsGCST9046979011.92
815FUT8/TNFSF12 ratioGCST9031489411.91
816T1 FreeSurfer BA rh V2 exvivo thicknessGCST9038557111.89
817Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T83ECGA00008311.87
818ADAMTSL2 levelsGCST9046822811.86
819Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T483ECGU00048311.86
820GRAP2/SNX9 ratioGCST9031498811.84
821T1 FreeSurfer DK rh superiorparietal thicknessGCST9038575111.81
822Heel bone mineral density (BMD) (left) | Bone-densitometry of heelUKBB0000031311.81
823Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T75ECGA00007511.80
824OsteomyelitisFING0000091111.79
825RABGAP1L levelsGCST9047041611.78
826neutrophil (absolute count, minimum, inv-norm transformed)GCST9047553211.77
827EDAR/EGF ratioGCST9031457311.76
828ACY3 levelsGCST9046821311.74
829Undecenoylcarnitine (C11:1) levelsGCST9020023611.72
830ENDOU levelsGCST9046910711.72
831PPP1R12A/SPARC ratioGCST9031571211.71
832Lignoceroylcarnitine (C24) levelsGCST9020013711.68
833TNFSF11 levelsGCST9027484411.66
834Charcot footFING0000026811.64
835IDP dMRI TBSS L1 Inferior cerebellar peduncle LGCST9000408611.64
836Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T171ECGA00017111.61
837PSCA levelsGCST9047035211.60
838Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T80ECGU00008011.60
839aparc-DKTatlas rh thickness postcentralGCST9000359111.59
840wg lh intensity-contrast superiorfrontalGCST9000381911.59
841COL4A1 levelsGCST9046881811.58
842PROS1 levelsGCST9047033711.58
843IDP dMRI ProbtrackX L1 cgc rGCST9000425111.58
844CEP112 levelsGCST9046870811.58
845Acetone levelsGCST9009280511.57
846WWP2 levelsGCST9047108011.56
847Pain type(s) experienced in last month - Knee pain | PainUKBB0000062911.55
848KRT5 levelsGCST9046971811.54
849SIGLEC7 levelsGCST9047063511.54
850SH2B3 levelsGCST9047061611.50
851ESAM/JAM2 ratioGCST9031471211.50
852PDE5A levelsGCST9047018711.49
853Recent feelings of depression | DepressionUKBB0000073711.49
854MED18/TBL1X ratioGCST9031541511.48
855C1R levelsGCST9046849311.47
856MAN2B2 levelsGCST9046984411.46
857Glutamine levelsGCST9009281811.46
858Right molecular layer hippocampal volume (body)GCST9026797511.46
859VNN2 levelsGCST9061851011.44
860Microalbumin urineGCST9027863911.44
861PDGFB levelsGCST9001201611.43
862Blood cell traits latent factor 10 (platelet)GCST9055925211.43
863ICAM5 levelsGCST9024154111.41
864CD74/NPDC1 ratioGCST9031389511.41
865Mid-point of the five least active hours of the dayGCST9006143411.39
866IFNAR1 levelsGCST9046951211.36
867F11R/GP1BA ratioGCST9031472211.35
868CALCOCO1/METAP2 ratioGCST9031360611.34
869aparc-a2009s rh volume G-occipital-supGCST9000301811.34
870aparc-a2009s lh volume G-front-inf-TriangulGCST9000293811.31
871KIR2DL2 levelsGCST9046968411.30
872Type of accommodation lived in - A flat, maisonette or apartment | HouseholdUKBB0000086811.28
873DTI autoptx L2 slf r tractGCST9038518811.28
874HS6ST2 levelsGCST9046948011.27
875DECR1 levelsGCST9046897811.23
876Retinal detachment with retinal defect | sense organsUKBB0000075411.22
877Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T224ECGU00022411.20
878Use of antiglaucoma preparations and mioticsFING0000140911.19
879aparc-a2009s lh area S-orbital-med-olfactGCST9000335911.16
880BST2/CEACAM1 ratioGCST9031353711.15
881MZB1/TNFRSF13B ratioGCST9031550911.11
882FOXO3/MAP3K5 ratioGCST9031488011.11
883Ptosis of eyelidFING0000122711.08
884NUDT2 levelsGCST9047010611.07
885ALCAM/MSR1 ratioGCST9031324011.03
886DKK1/PDGFA ratioGCST9031447511.02
887Left ventricular end diastole inferoseptal wall thicknessGCST9027851411.01
888ITGB1BP2/USP8 ratioGCST9031522310.99
889DAB2/ERBIN ratioGCST9031436110.99
890FABP2/RBP2 ratioGCST9031475710.97
891ASPSCR1 levelsGCST9046837810.94
892Takes medication for Glaucoma?GCST9047538410.93
893PIK3AP1/PSMG3 ratioGCST9031565110.92
894BA-exvivo lh volume V2GCST9000284510.91
895Atopic dermatitisGCST9002716110.90
896BA-exvivo rh volume BA3aGCST9000285110.90
897Cardiovascular delta age (difference between cardiac MRI-predicted and chronological age)GCST9023974810.90
898Nontoxic nodular goiter (PheCode 241)GCST9047563810.89
899DTI TBSS L2 Superior longitudinal fasciculus LGCST9038451710.86
900Maternal care for other conditions predominantly related to pregnancyFING0000079110.84
901INPPL1 levelsGCST9046961910.84
902Left-hemisphere dorsal attention network to putamen white-matter structural connectivityGCST9030270310.84
903SPARC levelsGCST9047071810.83
904wg lh intensity-contrast temporalpoleGCST9000382410.83
905DEFA1_DEFA1B/PTGDS ratioGCST9031445510.83
906CALCOCO1/MAP3K5 ratioGCST9031360510.82
907Acetone levels (UKB data field 23477)GCST9026957410.81
908IDP dMRI TBSS ICVF Superior fronto-occipital fasciculus RGCST9000436910.79
909STAT5B levelsGCST9047075910.78
910KLK8 levelsGCST9042231610.77
911TXLNA levelsGCST9047098910.76
912F2R/TNFRSF14 ratioGCST9031473910.75
913CANT1/VSIR ratioGCST9031362110.75
914Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T54ECGA00005410.74
915ESR1 levelsGCST9046915510.74
916Granulocyte countGCST00461410.73
917IDP T1 FAST ROIs V cerebellum XGCST9000258810.71
918red cell diameter width (RDW, mean, inv-norm transformed)GCST9047636110.70
919aparc-a2009s rh area G-precentralGCST9000339910.69
920Heel quantitative ultrasound index (QUI), direct entry (left) | Bone-densitometry of heelUKBB0000032210.68
921Heel bone mineral density (BMD) T-score, automated (left) | Bone-densitometry of heelUKBB0000031610.67
922CRADD/FKBP4 ratioGCST9031423810.65
923KLK8 levelsGCST9042549210.64
924CDH3/NECTIN4 ratioGCST9031395210.64
925MESD/SNX9 ratioGCST9031542310.61
926CASP3/SERPINB9 ratioGCST9031364210.61
927Blood cell traits latent factor 20 (red cell)GCST9055926210.60
928Cancer (standard GWA)GCST9026727010.58
929DTI autoptx L3 ilf r tractGCST9038520810.57
930Percentage of invited food questionnaires completedGCST9001279010.52
931Citrate levelsGCST9049720010.51
932CD40LG/EDAR ratioGCST9031381810.50
933Croissant likingGCST9009474810.47
934OSM/TGFA ratioGCST9031559010.47
935CST3/EFEMP1 ratioGCST9031429210.46
936DOK2/SNX9 ratioGCST9031453910.46
937Other specified disorders of external earFING0000110410.45
938PNMA1 levelsGCST9047027610.44
939Benign neoplasm: Adrenal glandFING0000016410.41
940CGREF1/FAM3C ratioGCST9031403210.40
941TREML1 levelsGCST9047096110.40
942Mean corpuscular haemoglobin concentration | Blood countUKBB0000044810.36
943FST levelsGCST9046927310.34
944DCXR levelsGCST9046896410.32
945Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T170ECGA00017010.32
946MPHOSPH8 levelsGCST9046993410.31
947Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T79ECGU00007910.30
948DTI autoptx MD ilf l tractGCST9038523410.29
949Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T26ECGA00002610.26
950FUT8/PDGFA ratioGCST9031489010.26
951Urine glycocholenate sulfate* levels in chronic kidney diseaseGCST9026529210.25
952AHCY levelsGCST9046825910.24
953CD8A levelsGCST9046865510.24
954Pain in thoracic spineFING0000113910.22
955BA-exvivo lh thickness BA3bGCST9000351610.21
956Reticulocyte fraction of red cellsGCST00461910.16
957CD74/JAM2 ratioGCST9031389310.15
958PM20D1 levelsGCST9047026810.15
959Diacylglycerol (14:0_18:2) levelsGCST9002470510.14
960CRADD/MAP4K5 ratioGCST9031424010.13
961ACVRL1/TNFRSF9 ratioGCST9031316010.12
962CCN2/ENO2 ratioGCST9031371210.12
963SERPINB1 levelsGCST9047058910.12
964DAPP1/PMVK ratioGCST9031439610.11
965IDP T1 FAST ROIs R front operc cortexGCST9000253210.08
966DAB2/LYN ratioGCST9031436510.08
967Drink temperatureGCST9013300210.07
968wg lh intensity-contrast caudalmiddlefrontalGCST9000379510.06
969MCFD2/VSIR ratioGCST9031541110.06
970GMFG levelsGCST9046936610.02
971aparc-Desikan rh area precentralGCST9000313010.01
972CANT1/NUDT5 ratioGCST903136199.99
973ACVRL1/SCARB2 ratioGCST903131579.98
974VSNL1 levelsGCST904710549.97
975CNPY4/MESD ratioGCST903141529.95
976IL1RAP levelsGCST904695739.93
977N6-methyllysine levels in chronic kidney diseaseGCST902575309.93
978Acquired toe deformities (PheCode 735.2)GCST904762499.91
979IPCEF1/SPARC ratioGCST903151869.91
980MB levelsGCST904698699.90
981REST UKBBICA NODEamps25 0003GCST903854869.90
982Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T220ECGU0002209.89
983FKBP4/RWDD1 ratioGCST903148409.89
984GlaucomaGCST900186329.88
985CSF2 levelsGCST904688849.87
986Takes medication for Sleep apnea?GCST904752589.86
987PPP1R2/TBL1X ratioGCST903157209.86
988CAMK1D levelsGCST902405569.85
989IDP dMRI TBSS L3 Splenium of corpus callosumGCST900041759.82
990Other retinal disordersFING000010949.82
991Hearing aid user | HearingUKBB000003099.81
992NFKBIE levelsGCST904700399.80
993TGFBI levelsGCST904708459.80
994Sleep disorders | Episodic and paroxysmal disordersUKBB000007759.77
995MITD1/SNX9 ratioGCST903154549.74
996IDP dMRI ProbtrackX ISOVF str rGCST900045499.74
997Operative procedures - Endoscopic resection of semilunar cartilage NEC | Summary OperationsUKBB000005779.74
998TNFRSF6B levelsGCST904709149.73
999CDH1 levelsGCST904686709.72
1000DFFA levelsGCST904689879.72